PDB22 LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART VERSUS SOLUBLE HUMAN INSULIN IN PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)62955-5 ◽

2005 ◽

Vol 8 (3) ◽

pp. 358-359 ◽

Author(s):

ME Minshall ◽

NS Twena ◽

L Nicklasson ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

The United Kingdom

Download Full-text

DB1 ESTIMATING THE LONG-TERM CLINICAL AND ECONOMIC BENEFITS OF INSULIN LISPRO IN TYPE 1 DIABETES IN THE UNITED KINGDOM: A COST-EFFECTIVENESS ANALYSIS BASED ON THE RESULTS OF A RECENT META-ANALYSIS

Value in Health ◽

10.1016/s1098-3015(10)66232-8 ◽

2008 ◽

Vol 11 (6) ◽

pp. A358

Author(s):

HT Smith ◽

WJ Valentine ◽

KS Boye ◽

A Kalsekar ◽

C Pratoomsoot

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Lispro ◽

Meta Analysis ◽

Economic Benefits ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text

936-P: Annual Cost to Achieve Cost Effectiveness of Continuous Glucose Monitoring in Hypoglycemia-Unaware Type 1 Diabetes Patients Using Intensive Insulin in the United Kingdom

Diabetes ◽

10.2337/db19-936-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 936-P

Author(s):

S. PINAR BILIR ◽

CARESSE CAMPBELL ◽

RICHARD HELLMUND ◽

JULIE MUNAKATA

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Continuous Glucose Monitoring ◽

Annual Cost ◽

Glucose Monitoring ◽

The United Kingdom ◽

Diabetes Patients

Download Full-text

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.685 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

B. Chubb ◽

M. Evans ◽

M. Wolden ◽

T. Christensen ◽

J. Gundgaard

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Insulin Degludec ◽

The United Kingdom ◽

Download Full-text

PDB52 Cost-Effectiveness of Renal Screening Strategies and Treatment Options for Patients With Type 1 Diabetes in the United Kingdom

Value in Health ◽

10.1016/j.jval.2012.03.973 ◽

2012 ◽

Vol 15 (4) ◽

pp. A180

Author(s):

T.W. Lung ◽

A.J. Hayes ◽

P.M. Clarke ◽

R.J. Stevens ◽

A. Farmer

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Treatment Options ◽

The United Kingdom ◽

Screening Strategies ◽

Renal Screening

Download Full-text

Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK

Current Medical Research and Opinion ◽

10.1185/03007990802668208 ◽

2009 ◽

Vol 25 (3) ◽

pp. 599-605 ◽

Author(s):

A. Lloyd ◽

C. Townsend ◽

V. Munro ◽

N. Twena ◽

S. Nielsen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Pregnant Women ◽

Human Insulin ◽

Insulin Aspart ◽

Download Full-text

Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom

Diabetes Obesity and Metabolism ◽

10.1111/dom.13992 ◽

2020 ◽

Vol 22 (7) ◽

pp. 1047-1055 ◽

Author(s):

Hayley Bennett ◽

Amarjeet Tank ◽

Marc Evans ◽

Klas Bergenheim ◽

Phil McEwan

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

The United Kingdom

Download Full-text

DB6 COMPARISON OF THE COST-EFFECTIVENESS FOR BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR+ INSULIN ASPART OR HUMAN INSULIN-BASED REGIMENS IN THE NETHERLANDS

Value in Health ◽

10.1016/s1098-3015(10)62626-5 ◽

2005 ◽

Vol 8 (3) ◽

pp. 255

Author(s):

Valentine Wj ◽

K Wittrup-Jensen ◽

AJ Palmer ◽

S Roze

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

The Netherlands ◽

Human Insulin ◽

Insulin Aspart ◽

Insulin Detemir ◽

The Cost ◽

Download Full-text

PDB20 LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE 1 DIABETES USING A BASAL-BOLUS REGIMEN IN BELGIUM, FRANCE, GERMANY, ITALY AND SPAIN

Value in Health ◽

10.1016/s1098-3015(10)66667-3 ◽

2008 ◽

Vol 11 (6) ◽

pp. A501-A502

Author(s):

MH Gschwend ◽

M Aagren ◽

WJ Valentine

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Neutral Protamine Hagedorn ◽

Download Full-text

Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation

Applied Health Economics and Health Policy ◽

10.1007/s40258-018-0379-5 ◽

2018 ◽

Vol 16 (3) ◽

pp. 357-366 ◽

Author(s):

William J. Valentine ◽

Kate Van Brunt ◽

Kristina S. Boye ◽

Richard F. Pollock

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Type 1 Diabetes Mellitus ◽

Effectiveness Evaluation ◽

Insulin Regimen ◽

Regular Human Insulin ◽

Download Full-text

Incidence of Euglycemic Diabetic Ketoacidosis in Adults With Type 1 Diabetes in the United Kingdom Before the Widespread Use of Sodium Glucose Cotransporter 2 Inhibitors

Mayo Clinic Proceedings ◽

10.1016/j.mayocp.2019.06.009 ◽

2019 ◽

Vol 94 (9) ◽

pp. 1909-1910 ◽

Author(s):

James Macfarlane ◽

Ketan Dhatariya

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Diabetic Ketoacidosis ◽

The United Kingdom ◽

Sodium Glucose Cotransporter ◽

Euglycemic Diabetic Ketoacidosis

Download Full-text